Intertek Group plc ITRK.L
Composite 60/100; the shares have moved about 33% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 38/100 — a moderate mark against it.
Momentum ranks 81/100 — a strong point in its favour. Quality ranks 73/100 — a moderate point in its favour. Income ranks 62/100 — a moderate point in its favour.
Growth ranks 38/100 — a moderate mark against it. Valuation ranks 44/100 — a slight mark against it.
What the company does Intertek Group plc provides quality assurance, testing, inspection, and certification services across Consumer Products, Corporate Assurance, Health and Safety, Industry and Infrastructure, and Energy segments. Its offerings include laboratory safety, supply-chain audits, sustainability verification, and cybersecurity solutions, serving global industries.
Key financials Intertek reports strong profitability with ROE 28.2%, ROA 9.9%, and ROCE 42.4%. Margins stand at gross 56.9%, operating 18.6%, and net 10.0%. Revenue growth is modest at 2.0%, while EPS declined -5.7%. Debt/Equity is 1.46, with net debt/EBITDA at 1.76 and interest coverage of 11.12.
Stock health The stock shows robust momentum with 3m +22.35%, 6m +29.81%, and 12m +18.53% gains. RSI(14) is 67.50, near overbought territory. Quality (74.5) and Income (70.9) pillars are strong, but Growth (31.2) lags peers.
Price vs fair value Intertek trades at a **PREMIUM of 31.30%** to our fair-value estimate and a **discount of 0.24%** to the 12-month target. - High profitability metrics (ROE 28.2%, ROCE 42.4%) support premium valuation (provided data). - Modest revenue growth (2.0%) and EPS decline (-5.7%) limit upside (provided data). - Strong momentum (6m +29.81%) and income (2.8% yield) justify near-term support (provided data). - Valuation percentile (40.4/100) suggests rich pricing relative to fundamentals (provided data).
Looking forward Forward P/E (22.37) and PEG (1.08) imply moderate earnings growth expectations. Analysts (n=13) see limited upside to the current price, balancing rich valuation with operational strength. Debt metrics remain manageable, but growth headwinds persist.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.